BioSpace News Archive

Verge Genomics, a drug discovery company developing therapies for neurological diseases by integrating a unique all-in-human genomic platform with machine learning, announced today that Steve Kanes, M.D., Ph.D., Chief Medical Officer at Sage Therapeutics, a leader in developing therapies that support brain health, has been appointed to its board of directors.

Stratasys Ltd. introduced a new 3D printer that gives dental labs 3D printing efficiency paired with PolyJet’s realism and precision.

Visus Therapeutics Inc. today announced the close of a $36 million Series A Preferred Stock financing. Johnson & Johnson Innovation - JJDC, Inc. (JJDC), RTW Investments, LP, and Wille AG participated in the round, with additional participation from the Company’s existing shareholders

Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has been named to Fast Company magazine’s list of 2021 Most Innovative Companies. Since 2008, the annual list has been the definitive source for recognizing the organizations that are transforming industries and shaping society.

9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, announced today that chief medical officer Patrick Griffin, M.D., FACP, will participate in an invited presentation at an upcoming virtual workshop entitled Accelerating Progress in Celiac Disease. The workshop is a National Institutes of Health workshop co-sponsored by the National Institute of Allergy and Infectious Diseases (NIAID)

Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced that it has completed enrollment of the first cohort of a Phase 2b clinical study evaluating the companys drug candidate EB01 as a monotherapy for chronic Allergic Contact Dermatitis (ACD), a potentially debilitating condition and occupational illness.

Moderna Named Fast Company ’s Most Innovative Company for 2021 Moderna ranked number 1 overall; also ranked number 1 in the biotechnology category

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the Oppenheimer 31st Annual Healthcare Conference on Thursday, March 18, 2021 at 11:20 a.m. ET.

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted T cells directly within the patient’s body, announced it will host a conference call and webcast to provide a business update on Tuesday, March 16, 2021 at 4:30 p.m. EDT.

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today announced that three late-breaking abstracts have been accepted for presentation at the 103rd Annual Meeting and Expo of the Endocrine Society (ENDO 2021) to be held virtually March 20-23.